These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29924019)

  • 21. Is JAK effective in treating recurrent SAPHO syndrome? TwHF might be a good choice.
    Sun Q; Gu Q; Jiang H; Li W; Lin Z; Li C; Ying Z
    Medicine (Baltimore); 2024 Jul; 103(29):e38848. PubMed ID: 39029083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study.
    Yamanaka H; Tanaka Y; Takeuchi T; Sugiyama N; Yuasa H; Toyoizumi S; Morishima Y; Hirose T; Zwillich S
    Arthritis Res Ther; 2016 Jan; 18():34. PubMed ID: 26818974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies.
    Fleischmann R; Kremer J; Tanaka Y; Gruben D; Kanik K; Koncz T; Krishnaswami S; Wallenstein G; Wilkinson B; Zwillich SH; Keystone E
    Int J Rheum Dis; 2016 Dec; 19(12):1216-1225. PubMed ID: 27451980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate.
    Fleischmann R
    Expert Opin Pharmacother; 2017 Oct; 18(14):1525-1533. PubMed ID: 28829236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome.
    Liu S; Li C; Tang MW; Xu WS; Chen KQ; Sui X; Tian XL; Xu KF
    Chin Med J (Engl); 2019 Oct; 132(19):2378-2379. PubMed ID: 31503058
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of baricitinib in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A case series.
    Liu S; Yu Y; Liu Y; Ma M; Li C
    Joint Bone Spine; 2023 Sep; 90(5):105587. PubMed ID: 37127258
    [No Abstract]   [Full Text] [Related]  

  • 27. Palmoplantar pustulosis presenting with chest pain. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.
    Hung CT; Wu BY
    JAMA Dermatol; 2013 Apr; 149(4):475-80. PubMed ID: 23715612
    [No Abstract]   [Full Text] [Related]  

  • 28. Current knowledge and future prospects for SAPHO syndrome.
    Kim C
    Drugs Today (Barc); 2014 Nov; 50(11):757-61. PubMed ID: 25525636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.
    Wallenstein GV; Kanik KS; Wilkinson B; Cohen S; Cutolo M; Fleischmann RM; Genovese MC; Gomez Reino J; Gruben D; Kremer J; Krishnaswami S; Lee EB; Pascual-Ramos V; Strand V; Zwillich SH
    Clin Exp Rheumatol; 2016; 34(3):430-42. PubMed ID: 27156561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAPHO syndrome in childhood. A case report.
    Vargas Pérez M; Sevilla Pérez B
    Reumatol Clin (Engl Ed); 2018; 14(2):109-112. PubMed ID: 27993538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor.
    Yang J; Yuan C; Zhou S; Teng Z; Li M
    Clin Cosmet Investig Dermatol; 2024; 17():529-537. PubMed ID: 38463557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.
    Curtis JR; Xie F; Yang S; Bernatsky S; Chen L; Yun H; Winthrop K
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1249-1254. PubMed ID: 30295428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gingival pustules and sterile diffuse sclerosing osteomyelitis as a feature of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
    Chou A; Schulman JM; Gross AJ; Jordan RC; Ramos DM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):e116-22. PubMed ID: 26619759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of SAPHO syndrome with apremilast.
    Adamo S; Nilsson J; Krebs A; Steiner U; Cozzio A; French LE; Kolios AGA
    Br J Dermatol; 2018 Oct; 179(4):959-962. PubMed ID: 29034454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAPHO: has the time come for tailored therapy?
    Figueiredo ASB; Oliveira AL; Caetano A; Moraes-Fontes MF
    Clin Rheumatol; 2020 Jan; 39(1):177-187. PubMed ID: 31312988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
    Clowse ME; Feldman SR; Isaacs JD; Kimball AB; Strand V; Warren RB; Xibillé D; Chen Y; Frazier D; Geier J; Proulx J; Marren A
    Drug Saf; 2016 Aug; 39(8):755-62. PubMed ID: 27282428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials.
    Huang F; Luo ZC
    Clin Rheumatol; 2019 Feb; 38(2):523-534. PubMed ID: 30242639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical.
    Tanaka Y; Yamaoka K
    Mod Rheumatol; 2013 May; 23(3):415-24. PubMed ID: 23212593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme.
    Curtis JR; Lee EB; Kaplan IV; Kwok K; Geier J; Benda B; Soma K; Wang L; Riese R
    Ann Rheum Dis; 2016 May; 75(5):831-41. PubMed ID: 25902789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SAPHO syndrome: a long-term follow-up study of 120 cases.
    Hayem G; Bouchaud-Chabot A; Benali K; Roux S; Palazzo E; Silbermann-Hoffman O; Kahn MF; Meyer O
    Semin Arthritis Rheum; 1999 Dec; 29(3):159-71. PubMed ID: 10622680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.